Zachary Taylor, attorney in the Health Care & Life Sciences practice, in the firm’s Newark office, was quoted in Bloomberg Health Law & Business News, in “Pharma, Device Deals Lead Pack as Health-Care Mergers Accelerate,” by Sara Hansard.
Following is an excerpt:
Health-care mergers and transactions surged in August, led by activity in the pharmaceutical and medical device sectors.
The 1,125 deals announced or closed by the end of August were well ahead of the 900 deals for the same period in 2019.
There were 166 deals in August alone. That number was the highest since January, attorneys and health-care analysts reported. …
Activity in the cannabis sector this year continued to exceed expectations, Zachary Taylor, an associate in the health-care and life sciences practice of Epstein Becker Green, said.
“This growth is likely due to the widespread confidence that more and more states will be expanding medical marijuana, as well as recreational use, over the next several years,” he said.
Five states will vote on legalizing marijuana this November: Arizona (recreational); Mississippi (medical); Montana (recreational); New Jersey (recreational); and South Dakota (medical and recreational), Taylor said. The Democratic Party, particularly vice presidential candidate Sen. Kamala Harris (D-Calif.), favors the decriminalization of marijuana, and that could be affecting the sector’s growth, he said.
